Montara Therapeutics Announces Development Candidate for First BrainOnly(TM)-Enabled Program in TSC-Related Epilepsy and Appoints Chief Business Officer GlobeNewswire December 08, 2025 Montara's BrainOnly platform is designed to prevent peripheral side effects and concentrate neurological drugs' activity in the brain via two-drug combination therapies, comprising its non-brain-penetrant “universal” peripheral blocker development candidate, MT1110, and a brain-penetrant […]

Kymera Therapeutics Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader, in Patients with Moderate to Severe Atopic Dermatitis GlobeNewswire December 08, 2025 KT-621 achieved deep STAT6 degradation across both the 100 mg and 200 mg dose groups tested, with median reductions of 94% and 98% in skin

Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting GlobeNewswire December 08, 2025 Joint presentation by Orchestra BioMed and Medtronic leadership to discuss ongoing strategic collaboration for development and commercialization of AVIM Therapy for treatment of uncontrolled hypertension in patients indicated for a pacemaker NEW HOPE, Pa., Dec. 08, 2025 (GLOBE

PyroGenesis Confirms Half-Tonne Order for Immediate Delivery of Titanium Metal Powder Represents first contract under Approved Supplier Status with Global Aerospace Leader GlobeNewswire December 08, 2025 MONTREAL, Dec. 08, 2025 (GLOBE NEWSWIRE) — PyroGenesis Inc. (“PyroGenesis”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), the leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology

Mercury Showcases Expanding Portfolio of Electronic Warfare Capabilities at AOC 2025 GlobeNewswire December 08, 2025 ANDOVER, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) — Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a global technology company that delivers mission-critical processing to the edge, will participate in this week's Association of Old Crows (AOC) International Symposium and Convention, showcasing

Gogo makes a strategic investment in Farcast to support new cutting-edge user terminal technology to enhance inflight connectivity for business, military, and government aviation GlobeNewswire December 08, 2025 SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) — Farcast, a San Francisco-based startup building advanced satellite user terminals, announces that it has received strategic equity investment from

OTC Markets Group Welcomes Bimini Capital Management, Inc. to OTCQX GlobeNewswire December 08, 2025 NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Bimini Capital Management, Inc. (OTCQX: BMNM), an asset manager that speacilizes in residential mortgage-related

Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse(R) Technology and Continuous-Wave Laser for Glaucoma Treatment GlobeNewswire December 08, 2025 MOUNTAIN VIEW, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) — Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the

Tecnoglass to Attend the Raymond James 2025 TMT & Consumer Conference GlobeNewswire December 08, 2025 Miami, FL, Dec. 08, 2025 (GLOBE NEWSWIRE) — Tecnoglass, Inc. (NYSE: TGLS) (“Tecnoglass” or the “Company”), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced that the

Copper Road signs Four Separate Option Agreements Consolidating the Ben Nevis Volcanic Complex into a Single Claim Group GlobeNewswire December 08, 2025 TORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) — Copper Road Resources Inc. (TSX-V: CRD) (“Copper Road” or the “Company”) is pleased to announce that it has signed a non-binding Letter of Intent (“LOI”) to